OurProducts

Prescription Cannabidiol (CBD)

EmpowerPharm is developing a prescription cannabidiol (CBD), designed to be consumed orally in a solid dose format. We source our CBD API from a Canadian supplier with a GMP facility approved by Health Canada.

SIGNIFICANT GLOBAL UNMET NEED IN SOCIAL ANXIETY DISORDER

References:
Global Social Anxiety Treatment Market, Forecast to 2030 – Infinity Business Insights
NIMH: Social Anxiety Disorder.

 

THE POTENTIAL BLOCKBUSTER SOLUTION...
PRESCRIPTION CBD,

Developing the world’s first CBD prescription medication indicated for Social Anxiety Disorder.

Prescription drug to be approved in USA, Canada, and globally, allowing patients to be reimbursed by insurance companies and drug formularies​

High quality standardized dosages with enhanced bioavailability and IP protection

Manufactured under GMP Standards at our own
facility with a Drug Establishment Licence

Alternative anxiety treatment, not physically addictive as with benzodiazepines, and with fewer side effects than anti-depressants (SSRI/SNRI)*

References:
* https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/

CANNABIDIOL SAFETY INFORMATION

References:
Detailed white paper on Cannabidiol safety and tolerability